Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: Associations with lesion grade, state of the HPV16 E2 gene and clinical outcome

British Journal of Cancer

Volumn 91, Issue 12, 2004, Pages 2063-2070

  Alazawi, W ^a,b   Pett, M ^a,b   Strauss, S ^c   Moseley, R ^d   Gray, J ^c   Stanley, M ^b   Coleman, N ^a,b,d  

^a HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Cervix; CGH; Papillomavirus; Recurrence

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CHROMOSOME 16Q; CHROMOSOME 1Q; CHROMOSOME 3Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA DETERMINATION; E2 GENE; FEMALE; FROZEN SECTION; GENOMIC INSTABILITY; GENOMICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICRODISSECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; VIRUS GENE;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA-BINDING PROTEINS; FEMALE; FROZEN SECTIONS; GENE DOSAGE; HUMANS; MICRODISSECTION; NEOPLASM RECURRENCE, LOCAL; NUCLEIC ACID HYBRIDIZATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 12344281908     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602237     Document Type: Article

References (50)

1. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J (1990) Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28: 495-503
2. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796-802
3. Chao A, Lin CT, Hsueh S, Chou HH, Chang TC, Chen MY, Lai CH (2004) Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Am J Obstet Gynecol 190: 1046-1051
4. Chatterjee A, Pulido HA, Koul S, Beleno N, Perilla A, Posso H, Manusukhani M, Murty VV (2001) Mapping the sites of putative tumor suppressor genes at 6p25 and 6p21.3 in cervical carcinoma: occurrence of allelic deletions in precancerous lesions. Cancer Res 61: 2119-2123
5. Chu TY, Shen CY, Lee HS, Liu HS (1999) Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution. Genes Chromosomes Cancer 24: 127-134
6. Chuaqui R, Silva M, Emmert-Buck M (2001) Allelic deletion mapping on chromosome 6q and X chromosome inactivation clonality patterns in cervical intraepithelial neoplasia and invasive carcinoma. Gynecol Oncol 80: 364-371
7. Chung TK, Cheung TH, Lo WK, Yu MY, Hampton GM, Wong HK, Wong YF (2000) Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intraepithelial neoplasia. Cancer Lett 154: 189-194
8. Costa S, De Simone P, Venturoli S, Cricca M, Zerbini ML, Musiani M, Terzano P, Santini D, Cristiani P, Syrjanen S, Syrjanen K (2003) Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecol Oncol 90: 358-365
9. Cruickshank ME, Sharp L, Chambers G, Smart L, Murray G (2002) Persistent infection with human papillomavirus following the successful treatment of high grade cervical intraepithelial neoplasia. Bjog 109: 579-581
10. Cuzick J. (1997) Viral load as a surrogate for persistence in cervical human papillomavirus infection. In New Developments in Cervical Cancer Screening and Prevention Franco E, Monsonego J (eds) Oxford, UK: Blackwell Science
11. Cuzick J, Terry G, Ho L, Monaghan J, Lopes A, Clarkson P, Duncan I (2000) Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 82: 1348-1352
12. Das BC, Sharma JK, Gopalakrishna V, Luthra UK (1992) Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol 73: 2327-2336
13. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP, Munger K (2000) The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 97: 10002-10007
14. Franco EL, Duarte-Franco E, Ferenczy A (2001) Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. Cmaj 164: 1017-1025
15. Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T (1996) Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93: 479-484
16. Holowaty P, Miller AB, Rohan T, To T (1999) Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 91: 252-258
17. Hulman G, Pickles CJ, Gie CA, Dowling FM, Stocks PJ, Dixon R (1998) Frequency of cervical intraepithelial neoplasia following large loop excision of the transformation zone. J Clin Pathol 51: 375-377
18. Jordens JZ, Lanham S, Pickett MA, Amarasekara S, Abeywickrema I, Watt PJ (2000) Amplification with molecular beacon primers and reverse line blotting for the detection and typing of human papillomaviruses. J Virol Methods 89: 29-37
19. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10: 231-243
20. Kirchhoff M, Rose H, Petersen BL, Maahr J, Gerdes T, Lundsteen C, Bryndorf T, Kryger-Baggesen N, Christensen L, Engelholm SA, Philip J (1999) Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chromosomes Cancer 24: 144-150
21. Kirchhoff M, Rose H, Petersen BL, Maahr J, Gerdes T, Philip J, Lundsteen C (2001) Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lesions. Cancer Genet Cytogenet 129: 47-51
22. Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, Wadell G, Angstrom T, Dillner J (2000) Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 82: 1332-1338
23. Klug SJ, Wilmotte R, Santos C, Almonte M, Herrero R, Guerrero I, Caceres E, Peixoto-Guimaraes D, Lenoir G, Hainaut P, Walboomers JM, Munoz N (2001) TP53 polymorphism, HPV infection, and risk of cervical cancer. Cancer Epidemiol Biomarkers Prev 10: 1009-1012
24. Konno R, Paez C, Sato S, Yajima A, Fukao A (1998) HPV, histologic grade and age. Risk factors for the progression of cervical intraepithelial neoplasia. J Reprod Med 43: 561-566
25. Larson AA, Liao SY, Stanbridge EJ, Cavenee WK, Hampton GM (1997) Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions. Cancer Res 57: 4171-4176
26. Lazo PA (1999) The molecular genetics of cervical carcinoma. Br J Cancer 80: 2008-2018
27. Lin WM, Michalopulos EA, Dhurander N, Cheng PC, Robinson W, Ashfaq R, Coleman RL, Muller CY (2000) Allelic loss and microsatellite alterations of chromosome 3p14.2 are more frequent in recurrent cervical dysplasias. Clin Cancer Res 6: 1410-1414
28. Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M (2002) Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360: 228-229
29. Luft F, Gebert J, Schneider A, Melsheimer P, von Knebel Doeberitz M (1999) Frequent allelic imbalance of tumor suppressor gene loci in cervical dysplasia. Int J Gynecol Pathol 18: 374-380
30. Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl-Erler ML (2000) Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 9: 1183-1191
31. Mohamed-Noor K, Quinn MA, Tan J (1997) Outcomes after cervical cold knife conization with complete and incomplete excision of abnormal epithelium: a review of 699 cases. Gynaecol Oncol 67: 34-38
32. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527
33. Nagai Y, Maehama T, Asato T, Kanazawa K (2000) Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence? Gynecol Oncol 79: 294-299
34. Pett MR, Alazawi WOF, Roberts I, Dowen S, Smith DI, Stanley MA, Coleman N (2004) Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res 64: 1359-1368
35. Plug-DeMaggio AW, Sundsvold T, Wurscher MA, Koop JI, Klingelhutz AJ, McDougall JK (2004) Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6. Oncogene 23: 3561-3571
36. Pulido HA, Fakruddin MJ, Chatterjee A, Esplin ED, Beleno N, Martinez G, Posso H, Evans GA, Murty VV (2000) Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer. Cancer Res 60: 6677-6682
37. Remmink AJ, Walboomers JM, Heimerhorst TJ, Voorhorst FJ, Rozendaal L, Risse EK, Meijer CJ, Kenemans P (1995) The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 61: 306-311
38. Roberts I, Gordon A, Wang R, Pritchard-Jones K, Shipley J, Coleman N (2001) Molecular cytogenetic analysis consistently identifies translocations involving chromosomes 1, 2 and 15 in five embryonal rhabdomyosarcoma cell lines and a PAX-FOXO1A fusion gene negative alveolar rhabdomyosarcoma cell line. Cytogenet Cell Genet 95: 134-142
39. Roberts I, Wienberg J, Nacheva E, Grace C, Griffin D, Coleman N (1999) Novel method for the production of multiple colour chromosome paints for use in karyotyping by fluorescence in situ hybridisation. Genes Chromosomes Cancer 25: 241-250
40. Sanoudou D, Tingby O, Ferguson-Smith MA, Collins VP, Coleman N (2000) Analysis of pilocytic astrocytoma by comparative genomic hybridization. Br J Cancer 82: 1218-1222
41. Sasieni PD (2000) Human papillomavirus screening and cervical cancer prevention. J Am Med Womens Assoc 55: 216-219
42. Stanley MA, Browne HM, Appleby M, Minson AC (1989) Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer 43: 672-676
43. Steenbergen RD, Walboomers JM, Meijer CJ, van der Raaij-Helmer EM, Parker JN, Chow LT, Broker TR, Snijders PJ (1996) Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene 13: 1249-1257
44. Steenbergen RDF, Kramer D, Meijer CJLM, Walboomers JMM, Trott DA, Cuthbert AP, Newbold RF, Overkamp WJI, Zdzienicka MZ, Snijders PJ (2001) Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line. J Natl Cancer Inst 93: 865-872
45. Strauss S, Jordens JZ, McBride D, Sonnex C, Edwards S, Desselberger U, Watt P, Gray JJ (1999) Detection and typing of human papillomavirus DNA in paired urine and cervical scrapes. Eur J Epidemiol 15: 537-543
46. Thorland EC, Myers SL, Persing DH, Sarkar G, McGovern RM, Gostout BS, Smith DI (2000) Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res 60: 5916-5921
47. Tonon SA, Picconi MA, Bos PD, Zinovich JB, Galuppo J, Alonio LV, Teyssie AR (2001) Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions. J Clin Virol 21: 129-134
48. Umayahara K, Numa F, Suehiro Y, Sakata A, Nawata S, Ogata H, Suminami Y, Sakamoto M, Sasaki K, Kato H (2002) Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chromosomes Cancer 33: 98-102
49. Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U, Doeberitz MK (2002) Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene 21: 419-426
50. Zitzelsberger H, Lehmann L, Werner M, Bauchinger M (1997) Comparative genomic hybridisation for the analysis of chromosomal imbalances in solid tumours and haematological malignancies. Histochem Cell Biol 108: 403-417